Produção Nacional
Osteonecrosis of the jaws in patients under osteoporosis treatment: a nine-year experience report
2023; Brazilian Society of Endocrinology and Metabolism; Volume: 67; Issue: 4 Linguagem: Inglês
10.20945/2359-3997000000612
ISSN2359-4292
AutoresDaniela Cia Penoni, João Vitor dos Santos Canellas, Marcos Antonio Nunes Costa Silami, Flávia Sader, Gonçalo Sobreira Pimentel, Anna Thereza Thomé Leão,
Tópico(s)Bone Tumor Diagnosis and Treatments
ResumoThis study aimed to report the experience of medication-related osteonecrosis of the jaws (MRONJ) in osteoporotic patients for nine years, and their associated initiating factors.The numbers of invasive oral procedures (IOP) (tooth extraction, dental implant placement, and periodontal procedures) and removable prostheses performed from January 2012 to January 2021 were obtained from the digital records of a large public dental center. There were an estimated 6,742 procedures performed in patients under osteoporosis treatment.Two cases (0.03%) of MRONJ were registered in nine years amongst patients with osteoporosis who had dental treatment at the center. From the 1,568 tooth extractions, one patient (0.06%) developed MRONJ. There was also one case from the 2,139 removable prostheses delivered (0.05%).The prevalence of MRONJ associated with osteoporosis treatment was very low. The protocols adopted seem to be adequate for the prevention of this complication. The findings of this study reinforce the rare frequency of MRONJ associated with dental procedures in patients submitted to the pharmacological management of osteoporosis. An integral analysis of systemic risk factors and oral preventive strategies may be considered regularly in the dental treatment of these patients.
Referência(s)